CIHR Team in Frailty and Aging  


Pierrette Gaudreau, PhD

Dr. Pierrette Gaudreau earned a doctorate in Pharmacology at the Université de Sherbrooke Faculty of Medicine and the National Institutes of Health (Bethesda, MD). She completed post-doctoral training in Neuroendocrinology at Université de Montréal, where she is a full professor in the Department of Medicine. She has received all grants available from the Fonds de la recherche en santé du Québec (FRSQ – “Quebec Health Research Fund”), including the prestigious national research scholar grant.

Dr. Gaudreau is the Director of the neuroendocrinology laboratory on aging at the CRCHUM and affiliated with several institutions, including the McGill Centre for Studies in Aging and the Centre de recherche de l’institut universitaire de gériatrie de Montréal. She served as the co-coordinator of the Quebec Network for Research on Aging “Nutrition and Successful Aging” reseach section, and is the co-coordinator of the Network’s “aging rat colony” infrastructure and coordinator of the biological sample bank for the NuAge cohort study. She was the Assistant Director of the Quebec Network for Research on Aging between January 2003 and March 2990 and has been Acting Director since April 2009.

She is a member of several institutional committees, and has been a scientific consultant for the FRSQ since 1993 and a member of the Conseil scientifique de la Société de Neuroendocrinologie de France since 2006. Her current research focuses on the neuroendocrinology of aging and, among other issues, is based on the study of the somatotropic function and the pituitary receptor of the growth hormone-releasing hormone factor as well as the understanding of the central and peripheral mechanisms contributing to somatopause and sarcopenia. She is also interested in developing nutritional and hormonal intervention strategies that may contribute to successful aging. More recently, she developed a new area of research dealing with the characterization and role of a new GHRH-R in the kidney and its role in renal protection.

She is a CIHR grant recipient and author/co-author of over 130 articles. Dr. Gaudreau is internationally recognized for her work on GHRH receptors. She holds Canadian, American and international patents for GHRH peptide receptor markers and superagonists. One of these (AKL-0707) was recently the subject of a Phase II clinical trial conducted by Akela Pharma Inc.

Pierrette Gaudreau, PhD
Department of Medicine, Université de Montréal
Laboratoire de Neuroendocrinologie du vieillissement
Centre de recherché du Centre hospitalier de l’Université de Montréal Angus Technopole
2901 Rachel St. East
Montreal, Quebec H1W 4A4
Tel.: 514-890-8000, Ext. 23613
Fax: 514-412-7638


© 2008-2013 CIHR Team in Frailty and Aging, All rights reserved
Updated February 11, 2013